Anish Thomas Selected Research

Anish Thomas Research Topics

Disease

67	Neoplasms (Cancer) 04/2024 - 06/2012
17	Mesothelioma 10/2021 - 07/2012
16	Lung Neoplasms (Lung Cancer) 01/2023 - 06/2012
15	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 04/2024 - 01/2014
14	Malignant Mesothelioma 10/2021 - 11/2014
8	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 11/2020 - 07/2012
8	Thymoma (Thymic Carcinoma) 01/2020 - 04/2013
7	Disease Progression 10/2021 - 02/2014
6	Adenocarcinoma of Lung 01/2020 - 04/2013
5	Genomic Instability 01/2024 - 11/2016
4	Ataxia Telangiectasia (Louis Bar Syndrome) 10/2023 - 12/2021
3	Breast Neoplasms (Breast Cancer) 11/2022 - 06/2016
3	Adenocarcinoma 01/2020 - 02/2015
3	Ovarian Neoplasms (Ovarian Cancer) 01/2020 - 01/2018
3	Prostatic Neoplasms (Prostate Cancer) 01/2019 - 01/2018
2	Microsatellite Instability 02/2024 - 01/2024
2	Pancreatic Neoplasms (Pancreatic Cancer) 12/2016 - 02/2015
2	Neoplasm Metastasis (Metastasis) 11/2016 - 05/2015
2	Carcinogenesis 06/2015 - 10/2013
1	Adrenocortical Carcinoma 03/2024
1	Leukemia 01/2023
1	Neuroendocrine Tumors (Neuroendocrine Tumor) 01/2023
1	Sarcoma (Soft Tissue Sarcoma) 03/2022
1	Aneuploidy (Aneuploid) 01/2022

Drug/Important Bio-Agent (IBA)

16	MesothelinIBA 11/2020 - 10/2013
11	DNA (Deoxyribonucleic Acid)IBA 01/2023 - 11/2010
9	PlatinumIBA 10/2023 - 01/2014
8	Biomarkers (Surrogate Marker)IBA 01/2020 - 11/2014
7	Immune Checkpoint InhibitorsIBA 01/2023 - 12/2016
7	Cisplatin (Platino)FDA LinkGeneric 01/2021 - 11/2014
5	Topotecan (Hycamtin)FDA LinkGeneric 10/2023 - 01/2018
5	Immunoconjugates (Immunoconjugate)IBA 01/2023 - 01/2016
5	Poly(ADP-ribose) Polymerase InhibitorsIBA 01/2023 - 01/2019
5	Immunotoxins (Immunotoxin)IBA 11/2020 - 10/2013
5	AntigensIBA 10/2019 - 07/2012
4	Proteins (Proteins, Gene)FDA Link 02/2024 - 01/2018
4	Irinotecan (Camptosar)FDA LinkGeneric 01/2023 - 01/2019
4	olaparibIBA 10/2021 - 01/2018
4	talazoparibIBA 01/2021 - 01/2018
4	AntibodiesIBA 10/2019 - 01/2010
4	ErbB Receptors (EGF Receptor)IBA 12/2016 - 07/2013
3	Phosphotransferases (Kinase)IBA 10/2023 - 06/2012
3	berzosertibIBA 10/2023 - 01/2023
3	Type I DNA Topoisomerases (Topoisomerase I)IBA 01/2023 - 12/2021
3	rucaparibIBA 11/2022 - 01/2018
3	LMB-100IBA 11/2020 - 01/2020
3	B7-H1 AntigenIBA 01/2020 - 01/2019
3	avelumabIBA 10/2019 - 11/2016
3	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2019 - 11/2014
3	Pemetrexed (MTA)FDA Link 01/2019 - 11/2014
3	Histone Deacetylase InhibitorsIBA 01/2018 - 11/2014
3	amatuximabIBA 12/2016 - 12/2014
3	Monoclonal AntibodiesIBA 01/2016 - 04/2013
3	Cyclophosphamide (Cytoxan)FDA LinkGeneric 08/2015 - 10/2013
2	Cytotoxins (Cytolysins)IBA 03/2024 - 01/2016
2	CyclinsIBA 02/2024 - 01/2024
2	PM 01183IBA 02/2024 - 01/2023
2	veliparibIBA 01/2023 - 01/2018
2	Gemcitabine FDA Link 01/2021 - 01/2019
2	pembrolizumabIBA 11/2020 - 01/2020
2	Surface Antigens (Surface Antigen)IBA 11/2020 - 11/2016
2	CamptothecinIBA 10/2020 - 01/2018
2	Temozolomide (Temodar)FDA LinkGeneric 01/2020 - 01/2017
2	anetumab ravtansineIBA 01/2020 - 12/2016
2	LigandsIBA 01/2019 - 11/2016
2	InterferonsIBA 01/2019 - 11/2016
2	Histones (Histone)IBA 01/2019 - 12/2014
2	Hydroxyurea (Hydrea)FDA LinkGeneric 01/2019 - 01/2018
2	niraparibIBA 01/2019 - 01/2018
2	Messenger RNA (mRNA)IBA 01/2019 - 01/2018
2	Tyrosine Kinase InhibitorsIBA 10/2016 - 06/2012
2	belinostatIBA 08/2015 - 11/2014
2	Membrane Glycoproteins (Membrane Glycoprotein)IBA 05/2015 - 12/2014
2	Immunoglobulin G (IgG)IBA 02/2015 - 03/2012
2	Sunitinib (Sutent)FDA Link 02/2015 - 04/2013
2	VaccinesIBA 08/2014 - 07/2012
1	Cell-Free Nucleic AcidsIBA 04/2024
1	TAK-243IBA 03/2024
1	Ubiquitin-Activating Enzymes (Ubiquitin-Activating Enzyme)IBA 03/2024
1	venetoclaxIBA 03/2024
1	Mitotane (Lysodren)FDA Link 03/2024
1	Proliferating Cell Nuclear Antigen (PCNA)IBA 02/2024
1	Cyclin D1IBA 01/2024
1	ALT-803IBA 03/2023
1	PoisonsIBA 01/2023
1	sacituzumab govitecanIBA 01/2023
1	Nucleosomes (Nucleosome)IBA 01/2023
1	Circular RNAIBA 01/2023
1	Topoisomerase I InhibitorsIBA 11/2022
1	TrabectedinIBA 03/2022
1	ChromatinIBA 01/2022
1	RNA Polymerase II (RNA Polymerase B)IBA 01/2022
1	UbiquitinIBA 01/2022
1	EnzymesIBA 12/2021
1	DNA Glycosylases (DNA Glycosylase)IBA 01/2021

Therapy/Procedure

33	Therapeutics 10/2023 - 10/2013
14	Drug Therapy (Chemotherapy) 10/2023 - 10/2013
6	Immunotherapy 01/2022 - 07/2012
2	Radiotherapy 11/2022 - 01/2018
1	Precision Medicine 09/2021